Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-039342
Filing Date
2023-06-23
Accepted
2023-06-23 16:14:24
Documents
1
Period of Report
2023-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4115
  Complete submission text file 0001209191-23-039342.txt   5569
Mailing Address 888 7TH AVENUE 12TH FLOOR NEW YORK NY 10106
Business Address
AGUIAR ERIC (Reporting) CIK: 0001262325 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 231037829

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations